Gemtuzumab ozogamicin

From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search

(gem-TOO-zoo-mab OH-zoh-ga-MIH-sin) A drug used to treat acute myeloid leukemia (AML) that is CD33 positive (expresses the protein CD33). It is used in patients whose disease is newly diagnosed. It is also used in patients aged 2 years or older whose disease has not gotten better with other treatment or has recurred (come back). Gemtuzumab ozogamicin contains a monoclonal antibody that binds to CD33, which is found on some leukemia cells. It also contains a toxic substance, which may help kill cancer cells. Gemtuzumab ozogamicin is a type of antibody-drug conjugate. Also called Mylotarg.

Learn more about Gemtuzumab ozogamicin

Latest research - Gemtuzumab ozogamicin

Clinical trials

External links

Medicine icon
Medicine icon

This WikiMD article Gemtuzumab ozogamicin is a stub. If you are familiar with the topic Gemtuzumab ozogamicin, you can help us. Paid editors welcome!


Gemtuzumab ozogamicin is part of WikiMD's free ^articles!

^Gemtuzumab ozogamicin (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Overweight?. W8MD's physician weight loss & sleep medicine program can HELP. Philadelphia lose weight. NYC lose weight Tele weight loss available